CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 392 enrolled
Drug / intervention
DabirAIR alternating pressure overlaydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02565797
NCT02565797N/ACompleted
CompareCT.gov

A Point-of-care, Pragmatic Comparative Prevention-effectiveness Trial of DabirAIR Alternating Pressure Overlay System to Reduce Hospital-acquired Pressure Ulcers in the Peri-operative Setting.

Dabir Surfaces Inc·interventional·Posted Oct 1, 2015·Updated Mar 29, 2021

In Brief

A clinical study evaluating DabirAIR alternating pressure overlay for Pressure Ulcer. Completed, enrolled 392 participants across 1 site.

Detailed Summary

Henry Ford Health System will evaluate the DabirAIR overlay system (DOS) for its effectiveness in preventing hospital acquired pressure ulcer (HAPU) in the peri-operative setting. The primary objective of the study is to compare the prevention-effectiveness (incidence rate of HAPU) between DOS (treatment group) vs facility specific standard of care pressure-relieving device(s) (control group) peri-operatively to discharge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPressure Ulcer
CountriesUnited States
CollaboratorsHenry Ford Health System

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 1, 2015
Enrollment StartNov 1, 2015
Primary CompletionNov 1, 2018
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 10.8 years ago

Interventions

DabirAIR alternating pressure overlaydevice

DabirAIR alternating pressure overlay is a dynamic support surface that is placed on top a mattress. The DabirAIR overlay provides periodic pressure relief through the alternate inflation and deflation of air cells.